{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:44:55Z","timestamp":1790009095453,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical Research Fund of Pirkanmaa Hospital District"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.clml.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T03:30:17Z","timestamp":1347507017000},"page":"363-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"12","author":[{"given":"Vesa","family":"Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Aittoniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juulia","family":"Jylh\u00e4v\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carita","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hurme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Paavonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simo S.","family":"Oja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"It\u00e4l\u00e4-Remes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjatta","family":"Sinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2012.06.001_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2012.06.001_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-cell chronic lymphocytic leukemia: a bird of a different feather","volume":"17","author":"Caligaris-Cappio","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2012.06.001_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2119\/2005-00011.Messmer","article-title":"Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status","volume":"10","author":"Messmer","year":"2004","journal-title":"Mol Med"},{"key":"10.1016\/j.clml.2012.06.001_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/1042819031000063408","article-title":"Vaccination against infections in chronic lymphocytic leukemia","volume":"44","author":"Sinisalo","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2012.06.001_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vaccine.2007.10.053","article-title":"Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia","volume":"26","author":"Sinisalo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.clml.2012.06.001_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","article-title":"Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?","volume":"20","author":"Mellor","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.clml.2012.06.001_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000133584","article-title":"Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12\u2013>p11 by fluorescent in situ hybridization","volume":"64","author":"Najfeld","year":"1993","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.clml.2012.06.001_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice","volume":"396","author":"Ball","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.clml.2012.06.001_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","article-title":"Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway","volume":"41","author":"Ball","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clml.2012.06.001_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clml.2012.06.001_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clml.2012.06.001_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-3-540-71029-5_8","article-title":"T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase","volume":"188","author":"Kahler","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.clml.2012.06.001_bib13","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1073\/pnas.0914347107","article-title":"B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase","volume":"107","author":"Johnson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clml.2012.06.001_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.leukres.2008.05.023","article-title":"Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia\/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity","volume":"33","author":"Hoshi","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2012.06.001_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.leukres.2008.06.014","article-title":"Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma","volume":"33","author":"Corm","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2012.06.001_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10522-010-9274-7","article-title":"Expression profiling of immune-associated genes in peripheral blood mononuclear cells reveals baseline differences in co-stimulatory signalling between nonagenarians and younger controls: the vitality 90+ study","volume":"11","author":"Jylh\u00e4v\u00e4","year":"2010","journal-title":"Biogerontology"},{"key":"10.1016\/j.clml.2012.06.001_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.mad.2006.01.020","article-title":"Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality","volume":"127","author":"Pertovaara","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.clml.2012.06.001_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1139\/o11-077","article-title":"Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy","volume":"90","author":"Cavia-Saiz","year":"2012","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.clml.2012.06.001_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1349-7006.2011.02158.x","article-title":"Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer","volume":"103","author":"Sim","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clml.2012.06.001_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3324\/haematol.2009.009647","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response","volume":"95","author":"Van Loo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2012.06.001_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3083.2010.02491.x","article-title":"New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins","volume":"73","author":"Sioud","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clml.2012.06.001_bib22","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar2361","article-title":"Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+regulatory T cells in Peyer\u2032s patches in an orally tolerized, collagen-induced arthritis mouse model","volume":"10","author":"Park","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clml.2012.06.001_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.leukres.2010.08.010","article-title":"Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease","volume":"35","author":"D'Arena","year":"2011","journal-title":"Leuk Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012001267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012001267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:21:58Z","timestamp":1761870118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265012001267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S2152265012001267"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2012.06.001","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2012.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}